Status:

COMPLETED

Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise

Lead Sponsor:

Jamie Burr

Conditions:

Cannabis

Cardiovascular Risk Factor

Eligibility:

All Genders

19-45 years

Phase:

EARLY_PHASE1

Brief Summary

This two-phase project seeks to examine the cardiovascular response to consumption of cannabis variants of different cannabinoid composition through different methods (smoking vs. vaporizing), at rest...

Eligibility Criteria

Inclusion

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 19-45yr
  • In good general health as evidenced by medical history and free of chronic disease
  • Must be experienced with cannabis use. This requires recreational cannabis use of a minimum of once per week in the past 30 days as confirmed by urine test
  • Experience consuming cannabis recreationally by vaping dried cannabis

Exclusion

  • Deemed unfit to exercise by the PARQ+.
  • Current or past diagnoses of substance abuse disorder
  • Failure of recreational substance urine screening test
  • Current, past, or strong family history of psychosis, or has previously experienced a cannabis-related psychotic episode
  • Current or past diagnoses of cannabis use disorder
  • Current or past diagnoses of any mood or anxiety disorder
  • Identified ECG abnormalities
  • Systolic blood pressure exceeding 160mmHg
  • Diastolic blood pressure exceeding 90mmHg
  • Resting heart rate exceeding 100bpm, or lower than 40bpm
  • Diagnosed with respiratory disease
  • Diagnosed with cardiovascular disease
  • Diagnosed with liver disease
  • Diagnosed with kidney disease
  • Is Pregnant or planning to be pregnant
  • Currently taking prescription medication (excluding contraceptive medication)
  • Is a cigarette smoker

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 16 2025

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT04693884

Start Date

September 1 2021

End Date

April 16 2025

Last Update

April 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Guelph

Guelph, Ontario, Canada, N1G2W1